These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38244844)
21. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy. Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476 [TBL] [Abstract][Full Text] [Related]
22. Dissolving Microneedles with Spatiotemporally controlled pulsatile release Nanosystem for Synergistic Chemo-photothermal Therapy of Melanoma. Qin W; Quan G; Sun Y; Chen M; Yang P; Feng D; Wen T; Hu X; Pan X; Wu C Theranostics; 2020; 10(18):8179-8196. PubMed ID: 32724465 [TBL] [Abstract][Full Text] [Related]
23. ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy. Yu M; Zeng W; Ouyang Y; Liang S; Yi Y; Hao H; Yu J; Liu Y; Nie Y; Wang T; Deng Y; Wu M Biomaterials; 2022 May; 284():121503. PubMed ID: 35367841 [TBL] [Abstract][Full Text] [Related]
24. Autophagy inhibition recovers deficient ICD-based cancer immunotherapy. Li J; Cai W; Yu J; Zhou S; Li X; He Z; Ouyang D; Liu H; Wang Y Biomaterials; 2022 Aug; 287():121651. PubMed ID: 35777331 [TBL] [Abstract][Full Text] [Related]
25. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Stagg J; Golden E; Wennerberg E; Demaria S Sci Immunol; 2023 Jul; 8(85):eabq3015. PubMed ID: 37418547 [TBL] [Abstract][Full Text] [Related]
27. Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy. Ma Y; Zhang Y; Li X; Zhao Y; Li M; Jiang W; Tang X; Dou J; Lu L; Wang F; Wang Y ACS Nano; 2019 Oct; 13(10):11967-11980. PubMed ID: 31553168 [TBL] [Abstract][Full Text] [Related]
31. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy. Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716 [TBL] [Abstract][Full Text] [Related]
33. Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases. Rahmaninejad H; Pace T; Chun BJ; Kekenes-Huskey PM Biophys J; 2022 Jan; 121(2):309-318. PubMed ID: 34922916 [TBL] [Abstract][Full Text] [Related]
34. Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine. Zhang Q; Huang W; Yuan M; Li W; Hua L; Yang Z; Gao F; Li S; Ye C; Chen Y; He J; Sun W; Yang X; Bai H; Ma Y ACS Appl Mater Interfaces; 2020 Dec; 12(49):54399-54414. PubMed ID: 33215918 [TBL] [Abstract][Full Text] [Related]
35. SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties. Warren MC; Matissek S; Rausch M; Panduro M; Hall RJ; Dulak A; Brennan D; Das Yekkirala S; Koseoglu S; Masia R; Yang Y; Reddy N; Prenovitz R; Strand J; Zaidi T; Devereaux E; Foissac CJ; Stagg J; Lee BH; Holland P; Palombella VJ; Lake AC Immunohorizons; 2023 May; 7(5):366-379. PubMed ID: 37219538 [TBL] [Abstract][Full Text] [Related]
36. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts. Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770 [TBL] [Abstract][Full Text] [Related]
37. Dual Stimuli-Responsive Micelles for Imaging-Guided Mitochondrion-Targeted Photothermal/Photodynamic/Chemo Combination Therapy-Induced Immunogenic Cell Death. Liang Y; Wang PY; Liu ZY; Sun HF; Wang Q; Sun GB; Zhang X; Li YJ; Xie SY Int J Nanomedicine; 2023; 18():4381-4402. PubMed ID: 37551273 [TBL] [Abstract][Full Text] [Related]
38. Targeting adenosine and regulatory T cells in cancer immunotherapy. Churov A; Zhulai G Hum Immunol; 2021 Apr; 82(4):270-278. PubMed ID: 33610376 [TBL] [Abstract][Full Text] [Related]
39. Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System. Wu L; Xie W; Li Y; Ni Q; Timashev P; Lyu M; Xia L; Zhang Y; Liu L; Yuan Y; Liang XJ; Zhang Q Adv Sci (Weinh); 2022 Jun; 9(17):e2105376. PubMed ID: 35396800 [TBL] [Abstract][Full Text] [Related]
40. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression. Hossain DMS; Javaid S; Cai M; Zhang C; Sawant A; Hinton M; Sathe M; Grein J; Blumenschein W; Pinheiro EM; Chackerian A J Clin Invest; 2018 Feb; 128(2):644-654. PubMed ID: 29337311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]